EP2252265A4 - Préparations injectables et leur procédé de préparation - Google Patents

Préparations injectables et leur procédé de préparation

Info

Publication number
EP2252265A4
EP2252265A4 EP09721586A EP09721586A EP2252265A4 EP 2252265 A4 EP2252265 A4 EP 2252265A4 EP 09721586 A EP09721586 A EP 09721586A EP 09721586 A EP09721586 A EP 09721586A EP 2252265 A4 EP2252265 A4 EP 2252265A4
Authority
EP
European Patent Office
Prior art keywords
preparation
injectable preparations
injectable
preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP09721586A
Other languages
German (de)
English (en)
Other versions
EP2252265A2 (fr
Inventor
Ashok Vasantray Vyas
Ravindra Tukaram Jadhav
Subhash Trimbak Phad
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Marvel Lifesciences Ltd
Original Assignee
Marvel Lifesciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marvel Lifesciences Ltd filed Critical Marvel Lifesciences Ltd
Publication of EP2252265A2 publication Critical patent/EP2252265A2/fr
Publication of EP2252265A4 publication Critical patent/EP2252265A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
EP09721586A 2008-02-19 2009-02-19 Préparations injectables et leur procédé de préparation Withdrawn EP2252265A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN356MU2008 2008-02-19
PCT/IN2009/000114 WO2009116077A2 (fr) 2008-02-19 2009-02-19 Préparations injectables et leur procédé de préparation

Publications (2)

Publication Number Publication Date
EP2252265A2 EP2252265A2 (fr) 2010-11-24
EP2252265A4 true EP2252265A4 (fr) 2011-04-20

Family

ID=41091337

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09721586A Withdrawn EP2252265A4 (fr) 2008-02-19 2009-02-19 Préparations injectables et leur procédé de préparation

Country Status (3)

Country Link
EP (1) EP2252265A4 (fr)
EA (1) EA201001327A1 (fr)
WO (1) WO2009116077A2 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007017713A1 (fr) * 2004-05-12 2007-02-15 Marvel Lifesciences Limited Substance possedant un effet antioxydant, geroprotecteur et anti-ischemique et procede de fabrication correspondant
WO2009116076A2 (fr) * 2008-02-19 2009-09-24 M. J. Biopharm Pvt.Ltd. Préparations ophtalmiques stériles et leur procédé de préparation
WO2009116078A2 (fr) * 2008-02-19 2009-09-24 M. J. Biopharm Pvt. Ltd. Formulations de dosage orales et leur procédé de préparation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007017713A1 (fr) * 2004-05-12 2007-02-15 Marvel Lifesciences Limited Substance possedant un effet antioxydant, geroprotecteur et anti-ischemique et procede de fabrication correspondant
WO2009116076A2 (fr) * 2008-02-19 2009-09-24 M. J. Biopharm Pvt.Ltd. Préparations ophtalmiques stériles et leur procédé de préparation
WO2009116078A2 (fr) * 2008-02-19 2009-09-24 M. J. Biopharm Pvt. Ltd. Formulations de dosage orales et leur procédé de préparation

Also Published As

Publication number Publication date
WO2009116077A3 (fr) 2009-12-23
WO2009116077A2 (fr) 2009-09-24
EA201001327A1 (ru) 2011-04-29
EP2252265A2 (fr) 2010-11-24

Similar Documents

Publication Publication Date Title
HK1250313A1 (zh) 穩定的藥物組合物和使用所述組合物的方法
HK1245785A1 (zh) 用於製備藥物藥劑的方法和中間體
EP2517851A4 (fr) Section en bois et procédé de préparation associé
EP2373679A4 (fr) Mini peptides d'hépcidine et leurs procédés d'utilisation
ZA201107702B (en) Composition and methods related to protein a(spa)variants
EP2450046A4 (fr) Composition à visée médicale pour le traitement de la bronchite et sa préparation
EP2339918A4 (fr) Préparation d'un quinolinyloxydiphénylcyclopropanedicarboxamide
ZA201109510B (en) Nanodispersion of a drug and process for its preparation
IL222576A0 (en) Fexofenadine-based composition and preparation process therefor
IL214402A0 (en) Transdermal pharmaceutical preparations
IL209919A0 (en) Process for preparing caspofungin and intermediates thereof
EP2424552A4 (fr) Compositions de ganoderma neuroprotectrices et procédés d'utilisation
HK1167592A1 (en) Cycloundecadepsipeptide compounds and use of said compounds as a medicament
HK1140777A1 (en) A type of consensus interferon and preparation method thereof
EP2394979A4 (fr) Intermédiaire de la cilastatine et sa méthode de préparation
ZA201204133B (en) Health-beneficial preparation and production method
EP2612671A4 (fr) Préparation clinique de scutellarine et procédé de préparation de celle-ci
EP2322505A4 (fr) Dérivé 1-adamantylazétidine-2-one et préparation pharmaceutique comprenant ce dérivé
EP2252265A4 (fr) Préparations injectables et leur procédé de préparation
ZA201108148B (en) Triazine-aryl-bis-indoles and process for preparation thereof
GB0821348D0 (en) Compounds and preparation methods
GB0901643D0 (en) Composite and process thereof
PL389953A1 (pl) Zakwas orkiszowo-owsiany oraz sposób przygotowania zakwasu orkiszowo-owsianego
GB0808285D0 (en) Preparation of methylenedioxybenzene and derivatives thereof
GB0803958D0 (en) Novel synthetic fuel and method of preparation thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20100917

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA RS

A4 Supplementary search report drawn up and despatched

Effective date: 20110323

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20111022